본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus 이용선
(암의생명과학과)
이용선:Enkhjin Saruuldalai :이휘호, 장지영, 황정아, 박은정, 이연수, 김인후, 이상진. A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus MOLECULAR THERAPY-ONCOLYTICS. 2022-02-20; 2022; 24:683~694. IF 7.2 (2020)
SARUULDALAI ENKHJIN
(암의생명과학과)
Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer Jae Myoung Noh(삼성서울병원)
Jae Myoung Noh(삼성서울병원):Kyungmi Yang(삼성서울병원), 서양권(국립암센터):신현주(삼성서울병원), 표홍렬(삼성서울병원), 문성호(국립암센터), 안용찬(삼성서울병원), 오동렬(삼성서울병원) 정은아(삼성서울병원), 조관현(삼성서울병원). Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer LIFE-BASEL. 2022-02-16; 2022; 12(2):292~. IF 3.817 (2020)
서양권
(방사선종양학과)
Combination of anti-PD-L1 antibody with peptide MEL-dKLA targeting M2 tumor-associated macrophages suppresses breast cancer metastasis Hyunsu Bae, Ik-Hwan Han
Hyunsu Bae, Ik-Hwan Han:이찬주:. Combination of anti-PD-L1 antibody with peptide MEL-dKLA targeting M2 tumor-associated macrophages suppresses breast cancer metastasis CANCER COMMUNICATIONS. 2022-02-16; 2022; 42(4):345~349. IF 10.392 (2020)
이찬주
(종양면역연구과)
Efficacy of Vitamin D Supplements in Prevention of Acute Respiratory Infection: A Meta-analysis for Randomized Con-trolled Trials 명승권
(암의생명과학과)
명승권:Hae-Eun Cho:. Efficacy of Vitamin D Supplements in Prevention of Acute Respiratory Infection: A Meta-analysis for Randomized Con-trolled Trials NUTRIENTS. 2022-02-15; 2022; 14(4):818~. IF 5.719 (2020)
Hae-Eun Cho
TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer Ik-Hwan Han, Hyunsu Bae
Ik-Hwan Han, Hyunsu Bae:이찬주:. TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022-02-15; 2022; 23(4):2157~. IF 5.924 (2020)
이찬주
(종양면역연구과)
Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study Jaeman Bae(한양의대)
Jaeman Bae(한양의대):Dong Wook Shin(성균관의대), 정규원:하조현. Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study JOURNAL OF GYNECOLOGIC ONCOLOGY. 2022-02-14; 2022; 33(2):e23~. IF 4.401 (2020)
정규원
(암등록감시부)
Trends in Incidence and Survival of Patients With Thymic Epithelial Tumor in a High-Incidence Asian Country: Analysis of the Korean Central Cancer Registry 1999 to 2017 정규원
(암등록감시부)
정규원:Dong Wook Shin(성균관대), Jong Ho Cho(성균과대):하조현. Trends in Incidence and Survival of Patients With Thymic Epithelial Tumor in a High-Incidence Asian Country: Analysis of the Korean Central Cancer Registry 1999 to 2017 JOURNAL OF THORACIC ONCOLOGY. 2022-02-11; 2022; Online:Published. IF 15.609 (2020)
Dong Wook Shin(성균관대), Jong Ho Cho(성균과대)
Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea Seungju Kim
Seungju Kim:한규태:. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea BMC CANCER. 2022-02-08; 2022; 22(1):156~. IF 4.43 (2020)
한규태
(암관리정책부)
Health-related quality of life among cancer patients and survivors and its relationship with current employment status Seungju Kim
Seungju Kim:한규태, 김우림:. Health-related quality of life among cancer patients and survivors and its relationship with current employment status SUPPORTIVE CARE IN CANCER. 2022-02-04; 2022; 30(5):4547~4555. IF 3.603 (2020)
한규태
(암관리정책부)
김우림
(암관리정책부)
Therapeutic Targeting of DNA Damage Response in Cancer 이은숙
(종양면역연구과)
이은숙:최원영:. Therapeutic Targeting of DNA Damage Response in Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022-02-01; 2022; 23(3):1701~. IF 5.924 (2020)
최원영
(암분자생물학연구과)